The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...

Nissan Motor unveiled sweeping new cost cuts, saying it would eliminate 11,000 more jobs and close 7 plants, capping a ...

Canadian pipeline operator Enbridge exceeded market estimates for first-quarter profit on Friday, driven in part by higher ...

SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

Royalty Receipts was $788 million in the first quarter of 2025, an increase of 12% compared to $705 million in the first quarter of 2024. The increase was primarily driven by strong growth from the ...

Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...

SaaS revenue grows 16% (constant currency1 17%), adjusted EBITDA1 margin of 25% Annual recurring revenue2 grows 14% (constant currency1 14%) FY 2025 guidance reiterated after solid first quarter ...

Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAGR of 7.5%. BURLINGAME, CA, UNI ...